Pneumomediastinum and Pneumothorax in COVID-19 Patients.docx (14.6 kB)
Pneumomediastinum and Pneumothorax in COVID-19 Patients
mediaposted on 2020-12-16, 22:19 authored by Alan Sihoe, Pierluigi Filosso, Giacomo Cusumano, Filippo Lococo, Franca Melfi
In May 2020, the SIET (Italian Society of Thoracic Endoscopy) organized a virtual roundtable of experts directly involved with the first phase of the SARS-CoV-2 pandemic. The aim was to share the experience acquired in the management of this disease in COVID-19 patients with severe clinical conditions requiring ventilatory assistance and endotracheal intubation. One of the main damages observed on these patients has been the high number of laryngo-tracheo-bronchial injuries, in addition to barotrauma lesions. This seems to be particularly related to the increasingly fragile tissues, especially in patients with specific comorbidities such as COPD, vascular diseases, diabetes, etc. This webinar was a great opportunity to discuss many aspects of this disease that are still unclear, and provide a perfect platform to share experiences, to improve the management of these kinds of patients with more appropriate indications, and then prove a correct diagnosis. Finally, the webinar has given the authors the chance to comment on the current status based on clinical experience through discussion of specific clinical cases.
Learn more: https://www.ctsnet.org/article/pneumomediastinum-and-pneumothorax-covid-19-patients